Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew G Bushmakin

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Postgraduate Medicine|November 2, 2020
Pain severity and healthcare resource utilization in patients with osteoarthritis in the United StatesSri Nalamachu, Rebecca L Robinson, Lars Viktrup, et al.
Dermatology and Therapy|March 17, 2021
Translating the Investigator's Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic DermatitisJacob P Thyssen, Chuanbo Zang, Maureen P Neary, et al.
Rheumatology and Therapy|June 23, 2023
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation AnalysisLars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE SustainLaura Targownik, Marla C Dubinsky, Flavio Steinwurz, et al.
Journal of Cancer Survivorship : Research and Practice|April 9, 2011
Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinomaPeter C Trask, Andrew G Bushmakin, Joseph C Cappelleri, et al.
Arthritis Research & Therapy|February 10, 2022
Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placeboDafna D Gladman, Laura C Coates, Joseph Wu, et al.
Arthritis Research & Therapy|March 26, 2021
Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinibLaura C Coates, Andrew G Bushmakin, Oliver FitzGerald, et al.
Journal of Clinical Medicine|January 21, 2023
Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic SurgeonsThomas J Schnitzer, Rebecca L Robinson, Lars Viktrup, et al.
Inflammatory Bowel Diseases|August 15, 2020
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction StudiesMarla C Dubinsky, Marco DiBonaventura, Haiyun Fan, et al.
Journal of Clinical Medicine|April 13, 2023
Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and SatisfactionThomas J Schnitzer, Rebecca L Robinson, Lars Viktrup, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Postgraduate Medicine|November 2, 2020
Pain severity and healthcare resource utilization in patients with osteoarthritis in the United StatesSri Nalamachu, Rebecca L Robinson, Lars Viktrup, et al.
Dermatology and Therapy|March 17, 2021
Translating the Investigator's Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic DermatitisJacob P Thyssen, Chuanbo Zang, Maureen P Neary, et al.
Rheumatology and Therapy|June 23, 2023
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation AnalysisLars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE SustainLaura Targownik, Marla C Dubinsky, Flavio Steinwurz, et al.
Journal of Cancer Survivorship : Research and Practice|April 9, 2011
Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinomaPeter C Trask, Andrew G Bushmakin, Joseph C Cappelleri, et al.
Arthritis Research & Therapy|February 10, 2022
Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placeboDafna D Gladman, Laura C Coates, Joseph Wu, et al.
Arthritis Research & Therapy|March 26, 2021
Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinibLaura C Coates, Andrew G Bushmakin, Oliver FitzGerald, et al.
Journal of Clinical Medicine|January 21, 2023
Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic SurgeonsThomas J Schnitzer, Rebecca L Robinson, Lars Viktrup, et al.
Inflammatory Bowel Diseases|August 15, 2020
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction StudiesMarla C Dubinsky, Marco DiBonaventura, Haiyun Fan, et al.
Journal of Clinical Medicine|April 13, 2023
Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and SatisfactionThomas J Schnitzer, Rebecca L Robinson, Lars Viktrup, et al.
Pageof 11